Cardinal Health $1.94 billion acquisition of Johnson & Johnson's Cordis business

4/10/2015

Private acquisition

Value:

$ 1.94 billion

Status:

Completed

Date:

4/10/2015

Overview:

Cardinal Health has acquired Johnson & Johnson's Cordis business for $1.94 billion.
The Corids business focuses on the development and manufacture of interventional vascular technology.
Johnson & Johnson is a medical device company.

Rani Mehta - Journalist

Jurisdiction:

United States

Deal type:

Private acquisition

Practice area:

M&A

Governing law:

United States

Industry sector:

Healthcare

Firms:

CMS von Erlach Partners

Party: Johnson & Johnson (Seller)

Lawyer: Stefan Brunnschweiler

Cravath Swaine & Moore

Party: Johnson & Johnson (Seller)

Lawyer: Robert Townsend III

Jones Day

Party: Cardinal Health (Acquirer)

Schellenberg Wittmer

Party: Cardinal Health (Acquirer)

Lawyer: Oliver Triebold

Related deals